Search our team at AdventHealth Research Institute
Showing 1 - 3 of 3 clinical trials matching your search
-
NCT03926130
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease.
This study is not currently enrolling.Associated Conditions: Inflammatory Bowel Disease (IBD)Research Area: Digestive Health and SurgeryThe main reason for you to take part in this study is not to treat you for your condition but to help in answering the following research questions:
How safe mirikizumab is and whether you might have... -
NCT02674308
Entyvio (vedolizumab) long-term study: An international observational prospective cohort study comparing vedolizumab to other biologic agents in patients with ulcerative colitis or Crohn's Disease. [Entyvio PASS Study]
This study is not currently enrolling.Associated Conditions: Inflammatory Bowel Disease (IBD)Research Area: Digestive Health and SurgeryThe purpose of this study is to obtain long-term safety information on the disease and medications that you received or are receiving for your Inflammatory Bowel Disease. Crohn’s Disease is...
-
NCT03279081
A Phase III, Randomized, Double Blind, Parallel Group, Placebo Controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-Derived Stem Cells (eASC), for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease Over a Period of 24 Weeks and a Follow-Up Period Up to 52 Weeks. ADMIRE-CD II Study.
This study is not currently enrolling.Associated Conditions: Inflammatory Bowel Disease (IBD)Research Area: Cancer ResearchThe purpose of this study is to confirm (1) how well the study drug works at a single dose of 120 million cells compared to a placebo; (2) how safe and tolerable the study drug is in patients with...